Back to Authors

Mishra, Ajay Kumar

https://orcid.org/0000-0003-4862-5053

Mayo Clinic

Manipal Academy of Higher Education

Citations 22

Latest updates on COVID‐2019: A changing paradigm shift
Sahu, Kamal Kant , Lal, Amos , Mishra, Ajay Kumar , Lal, Amos

Journal of Medical Virology | March 20, 2020 | Volume: 92 | Issue: 6 | Pages: 533-535

10.1002/jmv.25760 Get It

COVID‐2019 and pregnancy: A plea for transparent reporting of all cases
Sahu, Kamal Kant , Lal, Amos , Lal, Amos , Mishra, Ajay Kumar

Acta Obstetricia et Gynecologica Scandinavica | March 19, 2020 | Volume: 99 | Issue: 7 | Pages: 951-951

10.1111/aogs.13850 Get It

Stroke Symptoms in a Patient on 4-Factor Prothrombin Complex
Mishra, Ajay Kumar , Sahu, Kamal Kant , Lal, Amos , Mishra, Ajay K , Lal, Amos

Hospital Pharmacy | March 2, 2020 | Volume: 56 | Issue: 5 | Pages: 413-414

10.1177/0018578720910395 Get It

Coronavirus disease-2019: An update on third coronavirus outbreak of 21st century
Sahu, Kamal Kant , Mishra, Ajay Kumar , Lal, Amos , Mishra, Ajay K , Lal, Amos

QJM: An International Journal of Medicine | February 26, 2020 | Volume: 113 | Issue: 5 | Pages: 384-386

10.1093/qjmed/hcaa081 Get It

Methemoglobinemia in Transplant Recipient Patients: Future of Dapsone as Pneumocystis carinii Pneumonia Prophylaxis
Sahu, Kamal Kant , Lal, Amos , George, Susan, Lal, Amos , Mishra, Ajay Kumar

Progress in Transplantation | January 2, 2020 | Volume: 30 | Issue: 1 | Pages: 71-72

10.1177/1526924819893316 Get It

Systemic embolization following fungal infective endocarditis
Mishra, Ajay Kumar , Sahu, Kamal Kant , Lal, Amos , Sujata, M, Mishra, Ajay K , Lal, Amos

QJM: An International Journal of Medicine | October 24, 2019 | Volume: 113 | Issue: 3 | Pages: 233-235

10.1093/qjmed/hcz274 Get It

Acetaminophen induced methemoglobinemia
Sahu, Kamal Kant , Lal, Amos , George, Susan, Lal, Amos , Mishra, Ajay Kumar

Clinical Toxicology | October 17, 2019 | Volume: 58 | Issue: 7 | Pages: 784-785

10.1080/15563650.2019.1677909 Get It

Advancements in Treatment of Refractory and Relapsed Myeloid Sarcoma
Sahu, Kamal Kant , Lal, Amos , Mishra, Ajay Kumar , Lal, Amos

Journal of Oncology Practice | October 1, 2019 | Volume: 15 | Issue: 11 | Pages: 622-623

10.1200/jop.19.00447 Get It

Letter by Mishra et al Regarding Article, “Infection as a Stroke Trigger: Associations Between Different Organ System Infection Admissions and Stroke Subtypes”
Lal, Amos , George, Anu Anna , Lal, Amos , Mishra, Ajay Kumar

Stroke | September 26, 2019 | Volume: 50 | Issue: 11 | Pages: No page available

10.1161/strokeaha.119.026990 Get It

Assessing Anticoagulation Management and Shared Decision-Making Documentation from Providers Participating in the SUPPORT-AF Study
Hoque, Laboni, Amroze, Azraa , Gilvaz, Vinit, Mazor, Kathleen M. , McManus, David D. , Kapoor, Alok , Abraham, Sonu , Lal, Amos , Mishra, Ajay Kumar , Crawford, Sybil L.

No container title available | August 19, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.13133/v1 Get It

Abstract Background We previously tested an intervention featuring educational outreach with modified academic detailing (AD) to increase anticoagulation (AC) use in patients with atrial fibrillation (AF). Currently, we compare providers receiving and not receiving AD in terms of inclusion of our AD educational topics and shared decision-making elements in documentation. Methods Physicians reviewed themes discussed with providers during AD and evaluated charts for evidence of shared decision-making. We then compared frequency of documentation of individual items for providers receiving AD compared with non-AD providers. To understand baseline documentation practices of AD providers, we also randomly selected encounters of AD providers before their AD participation. Results There were 113 eligible encounters in the four months after AD - 36 from AD providers and 77 from non-AD providers. We also identified 35 encounters from AD providers before participating in the intervention. Providers infrequently documented many reviewed items (% documenting): AC mentioned (44%), multiple options for AC (5%), CHA2DS2-VASc score (11%), bleeding risk factors (2%). Compared with non-AD providers, AD providers had statistically significant higher percentages for the following items: mention of AC (64% versus 35%), stroke risk (11% versus 0%), AC benefits (8% versus 0%), patient involvement (70% versus 0%). There was no improvement, however, for AD providers compared with baseline documentation percentages. Conclusions Providers infrequently documented important items in AC management and shared decision-making. AD participation did not improve documentation. Improving adoption of AD educational items may require more prolonged interaction with providers. Improving shared decision-making may require an intervention more focused on it and its documentation. Trial Registration The trial was registered as NCT03583008 on Clinicaltrials.gov on July 11, 2018.